Cebu Medical Oncology Fellowship Training Program

Cebu Medical Oncology Fellowship Training Program Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Cebu Medical Oncology Fellowship Training Program, Hospital, Mandaue City, Cebu City.

Sometimes, the best investment in becoming a better physician is taking time to simply be human.This weekend, our Fellow...
15/07/2026

Sometimes, the best investment in becoming a better physician is taking time to simply be human.

This weekend, our Fellows-in-Training stepped away from hospital rounds and clinic schedules to reconnect with natureโ€”and with one anotherโ€”at Cebu Safari. Beyond the learning that happens within hospital walls, these shared moments of laughter, adventure, and friendship remind us that work-life balance is not a luxury but a necessity.

Caring for ourselves allows us to better care for our patients. Hereโ€™s to creating memories, strengthening our team, and returning with renewed energy and purpose. ๐ŸŒฟ๐Ÿฆ’๐Ÿ’š

Day 2 | RED Postgraduate CourseThe Section of Medical Oncology was well represented at the Chong Hua Hospital RED Postgr...
10/07/2026

Day 2 | RED Postgraduate Course

The Section of Medical Oncology was well represented at the Chong Hua Hospital RED Postgraduate Course as Dr. Michelle Oporto delivered an insightful lecture on Immunotherapy. Her expertise and thoughtful discussion highlighted the transformative role of immunotherapy in modern cancer care, providing valuable perspectives for clinical practice.

Grateful for the opportunity to learn from distinguished experts and to continue advancing our knowledge in the pursuit of excellence in patient care.

Day 1 of the Chong Hua Hospital RED Foundation Postgraduate Course! ๐ŸŽ‰ Ready to learn, grow, and embrace new opportunitie...
09/07/2026

Day 1 of the Chong Hua Hospital RED Foundation Postgraduate Course! ๐ŸŽ‰ Ready to learn, grow, and embrace new opportunities. Here's to another step in lifelong learning! ๐Ÿ“–โœจ

04/07/2026

๐—–๐—ฒ๐—ฏ๐˜‚ ๐—–๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฟ ๐—™๐—ฎ๐—ถ๐—ฟ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ invites you to a welcoming day of connection, care, and hope under the theme United by Unique: Different Stories. One Strength.

On Saturday, August 29, 2026, from 9 AM to 4 PM, join survivors, families, caregivers, and clinicians at Oakridge Pavilion in Mandaue City for inspiring survivor stories, wellness talks and activities, entertainment and musical numbers, and fun activities for kids.

Scan the QR code to register for free. Bring your loved ones for a friendly, informative experience that leaves you feeling informed and inspired.

See you there, Cebu!





FIRE-3 TrialThe FIRE-3 trial was a phase III, open-label, randomized study comparing FOLFIRI + cetuximab versus FOLFIRI ...
02/07/2026

FIRE-3 Trial
The FIRE-3 trial was a phase III, open-label, randomized study comparing FOLFIRI + cetuximab versus FOLFIRI + bevacizumab as first-line treatment for metastatic colorectal cancer. The primary efficacy analysis focused on patients with KRAS wild-type tumors.

FOLFIRI + cetuximab did not significantly improve the primary endpoint of objective response rate compared with FOLFIRI + bevacizumab. However, it was associated with longer overall survival, highlighting the importance of biologic selection in metastatic colorectal cancer.

Reference: Heinemann V, et al. Lancet Oncology. 2014.

Patients with refractory metastatic colorectal cancer (mCRC) have limited treatment options after progression on standar...
29/06/2026

Patients with refractory metastatic colorectal cancer (mCRC) have limited treatment options after progression on standard therapies. The FRESCO-2 Phase III, randomized, double-blind, placebo-controlled trial evaluated the efficacy of fruquintinib, a highly selective VEGFR inhibitor, in heavily pretreated patients across 124 centers in 14 countries.

๐Ÿ’ก Conclusion:
Fruquintinib treatment resulted in a significant and clinically meaningful benefit in overall survival compared with placebo in patients with refractory metastatic colorectal cancer. These findings support fruquintinib as an effective later-line treatment option for patients who have exhausted standard therapies.

๐Ÿ“– Reference: Dasari A, et al. Lancet. 2023;402:41โ€“53.

๐Ÿ’›๐ŸŽจ๐Ÿ’™ Brushing Away Fear and Anxiety Through Art Therapy ๐Ÿงก๐ŸŽจโค๏ธCancer survivors and their family members came together to ex...
17/06/2026

๐Ÿ’›๐ŸŽจ๐Ÿ’™ Brushing Away Fear and Anxiety Through Art Therapy ๐Ÿงก๐ŸŽจโค๏ธ

Cancer survivors and their family members came together to express their creativity and emotions through various art activities, including pottery painting, bag painting, diamond painting, and clay art. These hands-on experiences provided a relaxing and supportive environment where participants could ease fear and anxiety, strengthen family bonds, and celebrate their journey of healing and resilience.

Through every color, design, and creation, participants were reminded that hope, courage, and healing can be found in even the simplest acts of self-expression.
โœจ Celebrating survivorship, creativity, and the strength to keep moving forwardโ€”one brushstroke at a time.

๐ŸŽจ๐Ÿ’›๐Ÿงกโค๏ธ๐Ÿ’™

MAY is Skin and Bladder Cancer Awareness Month..Let us spread knowledge, encourage prevention, and inspire action. From ...
22/05/2026

MAY is Skin and Bladder Cancer Awareness Month..

Let us spread knowledge, encourage prevention, and inspire action.

From recognizing the ABCDE signs of melanoma to understanding the symptoms of bladder cancer, awareness is our first step in fighting cancer. Together, we can make a difference.โ€ ๐ŸŽ—๏ธ

Todayโ€™s Joint Multidisciplinary Team (MDT) conference at Chong Hua Hospital brought together the Section of Medical Onco...
30/04/2026

Todayโ€™s Joint Multidisciplinary Team (MDT) conference at Chong Hua Hospital brought together the Section of Medical Oncology and the Section of Infectious Disease for a meaningful and collaborative discussion.

Using a pancreatic cancer case as our take-off point, the team focused on the critical role of infection clearance prior to initiating chemotherapy. The discussion highlighted the importance of thorough patient evaluation, timely identification and management of infections, and coordinated decision-making to optimize treatment outcomes.

This collaboration underscores how integrated care across specialties ensures safer and more effective cancer management. By aligning oncologic goals with infection control strategies, we continue to strengthen patient-centered care and improve overall treatment readiness.

Looking forward to more collaborative MDTs that bridge expertise and enhance clinical practice.

Address

Mandaue City
Cebu City
6014

Website

Alerts

Be the first to know and let us send you an email when Cebu Medical Oncology Fellowship Training Program posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share